https://www.polity.org.za
Deepening Democracy through Access to Information
Home / Statements RSS ← Back
Africa|Health|Industrial|Innovation|Manufacturing|Technology|Manufacturing |Infrastructure
Africa|Health|Industrial|Innovation|Manufacturing|Technology|Manufacturing |Infrastructure
africa|health|industrial|innovation|manufacturing|technology|manufacturing-industry-term|infrastructure
Close

Email this article

separate emails by commas, maximum limit of 4 addresses

Sponsored by

Close

Article Enquiry

Ramaphosa to attend announcement by Dr Patrick Soon-Shiong of launch of NantAfrica Covid-19 and cancer vaccine

Close

Embed Video

Ramaphosa to attend announcement by Dr Patrick Soon-Shiong of launch of NantAfrica Covid-19 and cancer vaccine

Image of President Cyril Ramaphosa
President Cyril Ramaphosa

23rd September 2021

ARTICLE ENQUIRY      SAVE THIS ARTICLE      EMAIL THIS ARTICLE

Font size: -+

/ MEDIA STATEMENT / The content on this page is not written by Polity.org.za, but is supplied by third parties. This content does not constitute news reporting by Polity.org.za.

President Cyril Ramaphosa will be the guest of honour today, Thursday, 23 September 2021, at an announcement by Dr Patrick Soon-Shiong, founder of the multinational conglomerate, NantWorks LLC, of an initiative ambitious initiative to build capacity for advanced health care in Africa.

The initiative will entail collaboration among NantAfrica, the Council for Scientific and Industrial Research (CSIR), the South African Medical Research Council (SAMRC), the Centre for Epidemic Response and Innovation (CERI), and the universities of Cape Town, Witwatersrand, Stellenbosch and KwaZulu-Natal.

Advertisement

NantWorks is a multinational, California-based conglomerate that is leading the digital revolution in healthcare, technology and media through the harnessing of science, digital infrastructure, supercomputing and communication.

NantWorks LLC has signed a collaboration agreement with the CSIR and the SAMRC that will initiate the transfer of biologic manufacturing technology for COVID-19 and cancer vaccines and next-generation cell-based immunotherapies.

Advertisement

This will enable the rapid clinical development of next generation vaccines for infectious diseases and cancer at centres of excellence across the country. 

 

Issued by The Presidency

 

EMAIL THIS ARTICLE      SAVE THIS ARTICLE ARTICLE ENQUIRY

To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here

Comment Guidelines

About

Polity.org.za is a product of Creamer Media.
www.creamermedia.co.za

Other Creamer Media Products include:
Engineering News
Mining Weekly
Research Channel Africa

Read more

Subscriptions

We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store

Advertise

Advertising on Polity.org.za is an effective way to build and consolidate a company's profile among clients and prospective clients. Email advertising@creamermedia.co.za

View options
Free daily email newsletter Register Now
Register Close